Full Press Release Details
| November 25, 2019 | ||
| Corporate Relationship Department | National Stock Exchange of India Ltd. | |
| BSE Limited | "Exchange Plaza" | |
| Dalal Street, Fort | Bandra-Kurla Complex, Bandra (East), | |
| Mumbai - 400 001 | Mumbai - 400 051 | |
| Fax Nos.: 022-22723121 / 22723719 / | Fax Nos.: 022-26598120/ 26598237/ | |
| 22722037 / 22722039 | 26598238 | |
| Scrip Code: 500124 | Scrip Code: DRREDDY-EQ |
This is further to our intimation dated July 29, 2019 regarding the Scheme of Amalgamation and Arrangement between of Dr. Reddy's Holdings Limited ("DRHL" or "Amalgamating Company") and Dr. Reddy's Laboratories Limited ("Company" or "DRL" or "Amalgamated Company") and their respective shareholders, pursuant to provisions of Section 230-232, read with Section 66 of the Companies Act, 2013 and rules framed thereunder.
In this regard, we would like to inform you that the Hon'ble National Company Law Tribunal (NCLT), Hyderabad vide its order dated November 22, 2019, has directed the Company to convene the meeting of its equity shareholders and unsecured creditors on January 2, 2020, for seeking their approval to the said Scheme of Amalgamation and Arrangement.
This is for your information.
| With regards, | |
| /s/ Sandeep Poddar | |
| Sandeep Poddar | |
| Company Secretary |
CC:- New York Stock Exchange Inc.(Stock Code :RDY)